As techniques have been refined, interest in personalized mouse models of disease has risen, writes Andrew Pollack at The New York Times. While the use of such avatars has not been proven to affect patient outcomes and is expensive, Pollack says that some cancer patients are still trying that approach to learn more about how their cancers, implanted into mice, react to different drugs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.